| Screening (SCR) | Baseline (T0) | Intermediate (T1) | End-of-Treatment (T2) | Follow-up (T3) |
---|---|---|---|---|---|
 | Week 1 | Week 1 | Week 5 | Week 10 | Month 6 |
Clinician assessment | |||||
 M.I.N.I. 7.0.2 | • |  |  |  |  |
 LIFE |  |  |  |  | • |
 QIDS-C | • | •a | • | • | • |
 Demographic data |  | • |  |  |  |
Neuropsychological assessment | |||||
 MMST | • |  |  |  |  |
 CERADplus |  | • |  |  | • |
 NAB subtest maze |  | • |  |  | • |
 SCD Interview |  | • |  |  | • |
Questionnaires | |||||
 GDS | • | •a | • | • | • |
 GAI |  | • | • | • | • |
 PRO-MDD |  | • | • | • | • |
 WHOQOL OLD/BREF |  | • | • | • | • |
 SF36 |  | • | • | • | • |
 CTQ-SF |  | • |  |  |  |
 ESS |  | • | • | • | • |
 ISI |  | • | • | • | • |
 RBDSQ |  | • | • | • | • |
 BFI-10 |  | • |  |  |  |
 Patient satisfaction |  |  |  | • |  |
Blood sampling |  | • | • | • | • |
MRI |  | • |  | • | • |